MetaADEDB 2.0 @ LMMD
levocetirizine
(PGLIUCLTXOYQMV-GHVWMZMZSA-N)
Structure
SMILES
OC(=O)COCCN1CCN(CC1)[C@@H](c1ccc(cc1)Cl)c1ccccc1.Cl.Cl
Molecular Formula:
C21H27Cl3N2O3
Molecular Weight:
461.810
Log P:
4.6280
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
3
TPSA:
53.01
CAS Number(s):
130018-87-0
Synonym(s)
1.
levocetirizine
2.
(2-(4-((R)-(4-chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride
3.
(2-(4-((R)-p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic acid
4.
UCB-28556
5.
Xusal
6.
Xyzal
7.
acetic acid, (2-(4-((R)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-
8.
acetic acid, (2-(4-((R)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride
9.
cetirizine (R)-form dihydrochloride
10.
levocetirizine dihydrochloride
11.
levocetirizine hydrochloride
12.
levocetrizine
External Link(s)
MeSHC472067
PubChem Compound9955977
15977288
CHEMBLCHEMBL1201190
KEGGdr:D08118
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 819US FAERS
2SomnolenceFAERS: 434US FAERS
3FatigueFAERS: 131US FAERS
4Feeling abnormalFAERS: 108US FAERS
5HeadacheFAERS: 80US FAERS
6DizzinessFAERS: 62US FAERS
7SneezingFAERS: 59US FAERS
8HypersensitivityFAERS: 57US FAERS
9PruritusFAERS: 50US FAERS
10MalaiseFAERS: 38US FAERS
11Unevaluable eventFAERS: 37US FAERS
12Extra dose administeredFAERS: 33US FAERS
13Drug effect incompleteFAERS: 31US FAERS
14UrticariaFAERS: 29US FAERS
15EpistaxisFAERS: 26US FAERS
16NauseaFAERS: 25US FAERS
17Intentional product misuseFAERS: 21US FAERS
18AnxietyFAERS: 20US FAERS
19HypersomniaFAERS: 19US FAERS
20PainFAERS: 19US FAERS
21LethargyFAERS: 18US FAERS
22Adverse eventFAERS: 17US FAERS
23AgitationFAERS: 16US FAERS
24AstheniaFAERS: 16US FAERS
25Product packaging issueFAERS: 16US FAERS
26Product use issueFAERS: 16US FAERS
27Throat irritationFAERS: 16US FAERS
28Oropharyngeal painFAERS: 15US FAERS
29PalpitationsFAERS: 15US FAERS
30Product quality issueFAERS: 15US FAERS
31Wrong technique in product usage processFAERS: 15US FAERS
32Back PainFAERS: 10US FAERS
33OverdoseFAERS: 10US FAERS
34VomitingFAERS: 10US FAERS
35AngerFAERS: 9US FAERS
36Chest discomfortFAERS: 9US FAERS
37Eye irritationFAERS: 9US FAERS
38TremorFAERS: 9US FAERS
39Incorrect dose administeredFAERS: 8US FAERS
40No adverse eventFAERS: 8US FAERS
41Therapeutic response unexpectedFAERS: 8US FAERS
42Abdominal discomfortFAERS: 7US FAERS
43ArthralgiaFAERS: 7US FAERS
44Burning sensationFAERS: 7US FAERS
45Chest PainFAERS: 7US FAERS
46ConstipationFAERS: 7US FAERS
47CryingFAERS: 7US FAERS
48Drug dose omissionFAERS: 7US FAERS
49DysgeusiaFAERS: 7US FAERS
50ErythemaFAERS: 7US FAERS
51MyalgiaFAERS: 7US FAERS
52Nasal discomfortFAERS: 7US FAERS
53Product use in unapproved indicationFAERS: 7US FAERS
54VertigoFAERS: 7US FAERS
55Altered state of consciousnessFAERS: 6US FAERS
56Drug DependenceFAERS: 6US FAERS
57DysphoniaFAERS: 6US FAERS
58SinusitisFAERS: 6US FAERS
59ThirstFAERS: 6US FAERS
60Drug effect delayedFAERS: 5US FAERS
61DysuriaFAERS: 5US FAERS
62Feeling jitteryFAERS: 5US FAERS
63Head discomfortFAERS: 5US FAERS
64Inappropriate schedule of drug administrationFAERS: 5US FAERS
65Lip swellingFAERS: 5US FAERS
66Medication ErrorFAERS: 5US FAERS
67Nasal pruritusFAERS: 5US FAERS
68Product taste abnormalFAERS: 5US FAERS
69RestlessnessFAERS: 5US FAERS
70Sinus headacheFAERS: 5US FAERS
71SluggishnessFAERS: 5US FAERS
72SwellingFAERS: 5US FAERS
73Upper-airway cough syndromeFAERS: 5US FAERS
74Abdominal PainFAERS: 4US FAERS
75Accidental exposure to productFAERS: 4US FAERS
76Accidental overdoseFAERS: 4US FAERS
77AsthmaFAERS: 4US FAERS
78DehydrationFAERS: 4US FAERS
79Depressed moodFAERS: 4US FAERS
80Drug ToleranceFAERS: 4US FAERS
81Drug withdrawal syndromeFAERS: 4US FAERS
82Impaired driving abilityFAERS: 4US FAERS
83InfluenzaFAERS: 4US FAERS
84Memory impairmentFAERS: 4US FAERS
85NasopharyngitisFAERS: 4US FAERS
86Product physical issueFAERS: 4US FAERS
87Product size issueFAERS: 4US FAERS
88Product substitution issueFAERS: 4US FAERS
89Therapeutic product effect incompleteFAERS: 4US FAERS
90Urinary RetentionFAERS: 4US FAERS
91Visual ImpairmentFAERS: 4US FAERS
92Accidental drug intake by childFAERS: 3US FAERS
93Accidental exposure to product by childFAERS: 3US FAERS
94AmnesiaFAERS: 3US FAERS
95Angina PectorisFAERS: 3US FAERS
96AnosmiaFAERS: 3US FAERS
97Drug administration errorFAERS: 3US FAERS
98Euphoric moodFAERS: 3US FAERS
99Feeling ColdFAERS: 3US FAERS
100Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
101Intentional product use issueFAERS: 3US FAERS
102Loss of personal independence in daily activitiesFAERS: 3US FAERS
103Musculoskeletal stiffnessFAERS: 3US FAERS
104Neck PainFAERS: 3US FAERS
105NervousnessFAERS: 3US FAERS
106Obsessive thoughtsFAERS: 3US FAERS
107PoisoningFAERS: 3US FAERS
108Product blister packaging issueFAERS: 3US FAERS
109Product packaging quantity issueFAERS: 3US FAERS
110Product use complaintFAERS: 3US FAERS
111Productive CoughFAERS: 3US FAERS
112TachycardiaFAERS: 3US FAERS
113Toxicity to various agentsFAERS: 3US FAERS
114AlopeciaFAERS: 2US FAERS
115AngioedemaFAERS: 2US FAERS
116Bipolar DisorderFAERS: 2US FAERS
117Bladder painFAERS: 2US FAERS
118BronchitisFAERS: 2US FAERS
119ChillsFAERS: 2US FAERS
120Cold sweatFAERS: 2US FAERS
121DiplopiaFAERS: 2US FAERS
122DiscomfortFAERS: 2US FAERS
123Dreamy stateFAERS: 2US FAERS
124Drug effect faster than expectedFAERS: 2US FAERS
125Drug effect variableFAERS: 2US FAERS
126Drug effective for unapproved indicationFAERS: 2US FAERS
127Drug exposure during pregnancyFAERS: 2US FAERS
128Dry skinFAERS: 2US FAERS
129Ear discomfortFAERS: 2US FAERS
130Eye BurnsFAERS: 2US FAERS
131FlatulenceFAERS: 2US FAERS
132General physical health deteriorationFAERS: 2US FAERS
133GlaucomaFAERS: 2US FAERS
134ImpatienceFAERS: 2US FAERS
135Inappropriate schedule of product administrationFAERS: 2US FAERS
136IridocyclitisFAERS: 2US FAERS
137Joint swellingFAERS: 2US FAERS
138Limb discomfortFAERS: 2US FAERS
139Middle insomniaFAERS: 2US FAERS
140Mood swingsFAERS: 2US FAERS
141Night sweatsFAERS: 2US FAERS
142Peripheral swellingFAERS: 2US FAERS
143Product dose omissionFAERS: 2US FAERS
144Product label issueFAERS: 2US FAERS
145Pulmonary congestionFAERS: 2US FAERS
146Rash erythematousFAERS: 2US FAERS
147Renal painFAERS: 2US FAERS
148RhinitisFAERS: 2US FAERS
149Secretion dischargeFAERS: 2US FAERS
150SomnambulismFAERS: 2US FAERS
151TinnitusFAERS: 2US FAERS
152Urine amphetamine positiveFAERS: 2US FAERS
153treatment failureFAERS: 2US FAERS
154AcneFAERS: 1US FAERS
155Acquired von Willebrand's diseaseFAERS: 1US FAERS
156AgeusiaFAERS: 1US FAERS
157AphoniaFAERS: 1US FAERS
158ArthritisFAERS: 1US FAERS
159Bladder discomfortFAERS: 1US FAERS
160BlepharitisFAERS: 1US FAERS
161Blood creatinine increasedFAERS: 1US FAERS
162Blood glucose increasedFAERS: 1US FAERS
163Blood urine presentFAERS: 1US FAERS
164BradyphreniaFAERS: 1US FAERS
165BronchospasmFAERS: 1US FAERS
166CataractFAERS: 1US FAERS
167Cerebrovascular accidentFAERS: 1US FAERS
168CheilitisFAERS: 1US FAERS
169Choking sensationFAERS: 1US FAERS
170CholestasisFAERS: 1US FAERS
171ColitisFAERS: 1US FAERS
172Completed SuicideFAERS: 1US FAERS
173DeafnessFAERS: 1US FAERS
174DeliriumFAERS: 1US FAERS
175Deposit eyeFAERS: 1US FAERS
176Depressed Level of ConsciousnessFAERS: 1US FAERS
177Device ineffectiveFAERS: 1US FAERS
178Drug administered to patient of inappropriate ageFAERS: 1US FAERS
179Drug resistanceFAERS: 1US FAERS
180DyspepsiaFAERS: 1US FAERS
181DysphemiaFAERS: 1US FAERS
182DystoniaFAERS: 1US FAERS
183Emotional disorderFAERS: 1US FAERS
184Emotional distressFAERS: 1US FAERS
185Eosinophilic myocarditisFAERS: 1US FAERS
186Erectile dysfunctionFAERS: 1US FAERS
187Erection increasedFAERS: 1US FAERS
188ExophthalmosFAERS: 1US FAERS
189Eye painFAERS: 1US FAERS
190Eyelids pruritusFAERS: 1US FAERS
191Facial PainFAERS: 1US FAERS
192Feelings of worthlessnessFAERS: 1US FAERS
193FlushingFAERS: 1US FAERS
194Freezing phenomenonFAERS: 1US FAERS
195Frustration tolerance decreasedFAERS: 1US FAERS
196GastritisFAERS: 1US FAERS
197GoutFAERS: 1US FAERS
198HostilityFAERS: 1US FAERS
199HypoxiaFAERS: 1US FAERS
200Impaired work abilityFAERS: 1US FAERS
201Incorrect product administration durationFAERS: 1US FAERS
202Initial insomniaFAERS: 1US FAERS
203Joint stiffnessFAERS: 1US FAERS
204LacerationFAERS: 1US FAERS
205Lactose IntoleranceFAERS: 1US FAERS
206LazinessFAERS: 1US FAERS
207Limb injuryFAERS: 1US FAERS
208Long QT SyndromeFAERS: 1US FAERS
209LymphadenopathyFAERS: 1US FAERS
210Macular degenerationFAERS: 1US FAERS
211MastocytosisFAERS: 1US FAERS
212Mental FatigueFAERS: 1US FAERS
213Mental impairmentFAERS: 1US FAERS
214Motion SicknessFAERS: 1US FAERS
215Multiple allergiesFAERS: 1US FAERS
216Musculoskeletal PainFAERS: 1US FAERS
217Mycotic allergyFAERS: 1US FAERS
218MydriasisFAERS: 1US FAERS
219Myocardial InfarctionFAERS: 1US FAERS
220NocturiaFAERS: 1US FAERS
221Ocular discomfortFAERS: 1US FAERS
222Oral pruritusFAERS: 1US FAERS
223Packaging design issueFAERS: 1US FAERS
224PallorFAERS: 1US FAERS
225Paranasal sinus discomfortFAERS: 1US FAERS
226Paranasal sinus hypersecretionFAERS: 1US FAERS
227Paranasal sinus hyposecretionFAERS: 1US FAERS
228Perennial allergyFAERS: 1US FAERS
229PericarditisFAERS: 1US FAERS
230Personality ChangeFAERS: 1US FAERS
231PharyngitisFAERS: 1US FAERS
232Poor quality sleepFAERS: 1US FAERS
233PregnancyFAERS: 1US FAERS
234Product closure issueFAERS: 1US FAERS
235Product complaintFAERS: 1US FAERS
236Product contaminationFAERS: 1US FAERS
237Product package associated injuryFAERS: 1US FAERS
238Product packaging confusionFAERS: 1US FAERS
239Product prescribing issueFAERS: 1US FAERS
240Product shape issueFAERS: 1US FAERS
241Product storage errorFAERS: 1US FAERS
242Rectal dischargeFAERS: 1US FAERS
243Respiratory tract congestionFAERS: 1US FAERS
244Restless Legs SyndromeFAERS: 1US FAERS
245ScreamingFAERS: 1US FAERS
246Sedation complicationFAERS: 1US FAERS
247Sinus painFAERS: 1US FAERS
248Sleep ParalysisFAERS: 1US FAERS
249Slow response to stimuliFAERS: 1US FAERS
250StomatitisFAERS: 1US FAERS
251StressFAERS: 1US FAERS
252Suicide attemptFAERS: 1US FAERS
253SunburnFAERS: 1US FAERS
254SyncopeFAERS: 1US FAERS
255TachyphreniaFAERS: 1US FAERS
256Temperature intoleranceFAERS: 1US FAERS
257Therapeutic reaction time decreasedFAERS: 1US FAERS
258Therapeutic response changedFAERS: 1US FAERS
259Therapy cessationFAERS: 1US FAERS
260Tongue blisteringFAERS: 1US FAERS
261Urinary tract infectionFAERS: 1US FAERS
262Urine flow decreasedFAERS: 1US FAERS
263Violence-related symptomFAERS: 1US FAERS
264Wrong drug administeredFAERS: 1US FAERS
265Wrong product administeredFAERS: 1US FAERS
266prostatitisFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.